CSF2 and neutropenia: Granulocyte-colony-stimulating factor (G-CSF), granulocyte–macrophage colony-stimulating factor (GM-CSF), and pegylated G-CSF are effective at reducing risk and duration of neutropenia-related negative events [3, 4].